Betterchem
Health     Industry Portals     News     For Consumers     21CFR     Search     Site Map

 
LEVOFLOXACIN

 
 
Content specific to this active ingredient…

Drug Information
Prescribing and patient information from leading authorities

Drug Master Files
Type 2 master files on file at the FDA

Drug Recalls
For prescription drugs containing this active ingredient

Exclusivity
Patent and market exclusivity data

Federal Register
FR search results for this API

FDA Approved Labelling
Information found in this drug's package inserts

Research Links
Chemical identification and research citations

Title 21 Code of Federal Regulations
FDA regulations for this API

   

 


 

FDA Approval Activities for this Drug…

Levaquin, RW Johnson NDA 20-634, S004 & 20-635, S003 12/17/98 7/2/99 Levaquin Indications: uncomplicated urinary tract infection (UTI) Levaquin (levofloxacin) Tablets & Injection, Johnson & Johnson Pharmaceutical NDA 20-634/S28 & 20-635/S27 10/23/03 Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Research Institute NDA 20-634/S25 & 20-635/S22 10/30/02 1/29/03 10/31/02 Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Research Institute NDA 20-634/S15, S21 & S22 & 20-635/S12, S19 & S20 12/18/01 2/12/01 2/12/01 Levaquin (levofloxacin) Tablets & Injection, 250mg, 500mg, & 750mg / IV - 25mg/mL; 20 & 30mL(new) vials 5mg/mL; 50, 100, & 150mL(new), R.W. Johnson Pharmaceutical Research Institute NDA 20-634/S-013 & 20-635/S-010 9/8/00 9/12/00 9/12/00 Levaquin Indication: Treatment of complicated skin and skin structure infections. Levaquin Tablets,250mg and 500mg / Levaquin Injection,25mg/ml and 5mg/ml, R.W. Johnson Pharmaceutical Research Institute NDA 20-634/S-008 & 20-635/S-007 2/2/00 2/3/00 Levaquin Indication: Treatment of levofloxacin-susceptible strains of penicillin-resistant Steptococcus pneumoniae in patients with community acquired pneumonia. Quixin (levofloxacin ophthalmic solution), 0.5%, Santen Incorporated NDA 21-199/S3 6/4/02 6/17/02 6/7/02 Quixin (levofloxacin ophthalmic solution), 0.5%, Santen Incorporated NDA 21-199/S2 4/18/02 4/22/02 4/18/02 Quixin (levofloxacin ophthalmic solution) Sterile, 0.5%, Santen Incorporated NDA 21-199 8/18/00 8/28/00 8/28/00 Quixin Indications: treatment of bacterial conjunctivitis. Levaquin (levofloxacin) Tablets & Injection, Johnson & Johnson Pharmaceutical LEVOFLOXACIN Injection 25MG/ML LEVAQUIN ORTHO MCNEIL 020635 LEVOFLOXACIN Injection 500MG/100ML LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL 020635 LEVOFLOXACIN Injection 5MG/ML LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER ORTHO MCNEIL 021199 LEVOFLOXACIN Solution/Drops; Ophthalmic 0.5% QUIXIN SANTEN 020634 LEVOFLOXACIN Tablet; 250MG LEVAQUIN ORTHO MCNEIL 020634 LEVOFLOXACIN Tablet; 500MG LEVAQUIN ORTHO MCNEIL 020634 LEVOFLOXACIN Tablet; 750MG LEVAQUIN ORTHO MCNEIL Iquix (Levofloxacin) Opthalmic Solution, Santen Incorporated Levaquin (levofloxacin) Tablets & Injection, R.W. Johnson Pharmaceutical Levofloxacin Tablets, Teva Pharmaceuticals, Levofloxacin Injection, Bedford Laboratories | Levofloxacin Tablets, Ranbaxy, Inc., Tentative Approval | LEVAQUIN (levofloxacin) Injection, R.W. Johnson Pharmaceutical, Labeling Revision | LEVAQUIN (levofloxacin) Tablets R.W. Johnson Pharmaceutical, Labeling Revision | Levofloxacin Tablets, Myland Pharma, Approval | Levaquin (Levofloxacin) Oral Solution, J & J Pharmaceuticals, Approval | LEVAQUIN (levofloxacin) Tablets, Ortho McNeil Pharma, Labeling Revision | LEVAQUIN (levofloxacin) Injection, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Tablets, Ortho-McNeil, New or Modified Indication | Levaquin (Levofloxacin) Injection, Ortho-McNeil, New or Modified Indication | Levaquin (Levofloxacin) Oral Solution, Ortho-McNeil, New or Modified Indication | Levofloxacin Tablet (750mg), Teva Pharma, Approval | Levofloxacin Injection, Sicor Pharma, Tentative Approval | Levofloxacin Tablets, Mylan Pharma, Tentative Approval | Levofloxacin Ophthalmic Solution, Hi-Tech Pharmacal, Tentative Approval | Quixin (levofloxacin ophthalmic solution), Santen Inc., Labeling Revision & Package Change | Levofloxacin Tablets, Dr. Reddy's Labs, Tentative Approval | Levofloxacin Tablets, IVAX Pharma, Tentative Approval | Levofloxacin (in 0.9% sodium chloride) Injection, SICOR Pharma, Approval | Levaquin (Levofloxacin) Tablet, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Injection, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Oral Suspension, Ortho McNeil Pharma, New Dosage Regimen | Levaquin (Levofloxacin) Tablets, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Injection, Ortho McNeil Pharma, Labeling Revision | Levaquin (Levofloxacin) Oral Solution, Ortho McNeil Pharma, Labeling Revision | Levofloxacin Tablets, Zydus Pharma, Tentative Approval | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Patient Population Altered | Levaquin (levofloxacin) Injection and Levaquin (levofloxacin in dextrose) Injection, Ortho-McNeil Pharma, Patient Population Altered | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Patient Population Altered | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, New Dosage Regimen | Levaquin (levofloxacin) Injection and Levaquin (levofloxacin in 5% dextrose) Injection, Ortho-McNeil Pharma, New Dosage Regimen | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, New Dosage Regimen | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection and Levaquin (levofloxacin in 5% dextrose) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection and Levaquin (levofloxacin in 5% dextrose) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin in Dextrose 5% in Plastic Container (levofloxacin) Injection, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil Pharma, Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho-McNeil-Janssen Pharmaceutical, Inc., Patient Population Altered | Levaquin (levofloxacin) Injection, Ortho-McNeil-Janssen Pharmaceutical, Inc., Patient Population Altered | Levaquin in Dextrose 5% in Plastic Container (levofloxacin) Injection, Ortho-McNeil-Janssen Pharmaceutical, Inc., Patient Population Altered | Levaquin (levofloxacin) Oral Solution, Ortho-McNeil-Janssen Pharmaceutical, Inc., Patient Population Altered | Levaquin (levofloxacin) Oral Solution, Ortho McNeil-Janssen Pharmaceutical, Inc., Labeling Revision | Levaquin (levofloxacin) Tablets, Ortho McNeil-Janssen Pharmaceutical, Inc., Labeling Revision | Levaquin In Dextrose 5% In Plastic Container (levofloxacin) Injection, Ortho McNeil-Janssen Pharmaceutical, Inc., Labeling Revision

^ FDA's latest approval appears at the bottom of this list. ^


 

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News

© 2008 Betterchem.com